Influence of Catastrophism in Fibromyalgia Patients Following Dry Needling Treatment
Lykilorð
Útdráttur
Lýsing
Fibromyalgia syndrome (FS) is currently classified as chronic widespread pain with widespread allodynia (Coster et al., 2008). These symptoms are accompanied by other disorders, such as sleep disturbance, headaches, morning stiffness, irritable bowel syndrome, interstitial cystitis, dyspareunia, mood disturbances and depression (Gerwin, 2005). The World Health Organization recognized FS as a disease in 1992, basing its decision on the diagnostic criteria of the American College of Rheumatology (ACR) which has recently been criticized and updated (Wolfe et al., 2011; Wolfe et al., 2010; Wolfe and Hauser, 2011). Depending on the diagnostic criteria used, the prevalence is from 2% to 8% of the population increasing with age, with highest values attained between 60 and 70 (Stahl, 2009). In Spain, was estimated that 2.4% of the population over 20 years old presents the disease, and it is higher in females than in males (ratio 21:1) (Cordero, 2011).
A central sensitivity syndrome could be the most plausible explanation for chronic widespread pain affecting people with fibromyalgia syndrome. Although it was suggested this condition was the sole cause (Yunus, 2007), central sensitization of the nervous system causes the phenomena of hyperalgesia and allodynia in the individual suffering from chronic pain (Butler and Moseley, 2003) .
The subject with chronic pain has an altered alarm system; this alteration could be initiated by a peripheral sensitization (Sarzi-Puttini et al., 2011) activated by the release of various chemical substances such as substance P, serotonin and bradykinin (Yunus, 2007). Myofascial trigger points (MTrPs) are able to maintain this peripheral sensitization (Affaitati et al., 2011; Ge et al., 2010) by triggering the spontaneous pain patterns experienced by a patient with fibromyalgia syndrome (Ge et al., 2011).
MTrPs contain algogenic substances capable of generating changes in the intensity of pain. Differences in the concentration of these substances between healthy muscle and MTrPs (Shah et al., 2005) have been shown. One of the most effective techniques for the treatment of MTrPs is dry needling (Mayoral, 2010), because it alters the chemical environment of the MTrPs, thus decreasing their sensitization (Dommerholt, 2011). However, there are as until no few studies that have examined the effectiveness of this technique in patients with FS (Chou et al., 2008; Staud, 2006). Moreover, in these patients the perception of pain during and after treatment can be influenced not only by central sensitization, but also by psychosocial variables.
Catastrophization, considered to be the basic psychological construction concerning the perception of pain intensity, is a cognitive and emotional process encompassing magnification of pain-related stimuli, feelings of helplessness, and a generally pessimistic orientation (Labus et al., 2003; Rodero et al., 2010). This catastrophization, understood as a set of negative emotions and cognitive processes, is a risk factor in fibromyalgia and leads to an increase in symptoms, health status warning, symptoms of helplessness and pessimism (Alegre de Miquel and Sellas Fernandez, 2008; Sullivan et al., 2001).
These negative thoughts lead to alterations in the function of the descending inhibitory pathways that modulate pain (Wideman and Sullivan, 2011) producing an increase in the pain's intensity and exaggerated pain behavior (Wideman and Sullivan, 2012). Several lines of research suggest that this psychological construct is an indicator of poor results obtained from various treatments (surgical, pharmacological and psychological interventions in pain management) (Sullivan et al., 2009; Mankovsky et al., 2012; Sullivan et al., 2005).
Catastrophizing is an important factor in the pathophysiological FM, which also influences the perception of pain and the effects of the various treatments mentioned above. Several studies have shown that catastrophizing increases attention at the site of injury and increases the fear of pain that patient refers (McMahon et al., 2013; Sullivan et al., 2001). However, how this psychological construct may influence both factors - the treatment effectiveness of MTrPs by dry needling and the perception of pain during this treatment - is still unknown.
Subjects who experience high levels of catastrophizing have been demonstrated as having increased emotional and physical stress in response to a painful episode. It would therefore be interesting to analyze whether high levels of catastrophizing may influence and be related with high levels of perceived pain during and after dry needling treatment.
The main objective of our study is to assess whether catastrophizing could influence the perception of pain during and after dry needling application.
Dagsetningar
Síðast staðfest: | 05/31/2020 |
Fyrst lagt fram: | 01/19/2020 |
Áætluð skráning lögð fram: | 01/21/2020 |
Fyrst sent: | 01/22/2020 |
Síðasta uppfærsla lögð fram: | 06/16/2020 |
Síðasta uppfærsla sett upp: | 06/17/2020 |
Raunverulegur upphafsdagur náms: | 01/06/2020 |
Áætlaður aðallokunardagur: | 06/30/2020 |
Áætlaður dagsetningu rannsóknar: | 06/30/2020 |
Ástand eða sjúkdómur
Íhlutun / meðferð
Procedure: Dry needling
Stig
Armhópar
Armur | Íhlutun / meðferð |
---|---|
Experimental: Dry needling group Patients treated with dry needling | |
Sham Comparator: Sham group Patients treated with a simulated dry needling | |
No Intervention: Control Patients never treated |
Hæfniskröfur
Aldur hæfur til náms | 35 Years Til 35 Years |
Kyn sem eru hæf til náms | Female |
Tekur við heilbrigðum sjálfboðaliðum | Já |
Viðmið | Inclusion Criteria: - A diagnosis of fibromyalgia verified by a qualified rheumatologist according to the ACR criteria - To have basic spanish skills (be able to understand oral and written spanish language) Exclusion Criteria: - Belonephobia or mimicking pathologies - Lymphedema - Pregnancy - Neoplastic disorders |
Útkoma
Aðal niðurstöður ráðstafanir
1. The Pain Catastrophizing Scale (PCS) is a 13-item self-administered scale and one of the most widely used to assess pain catastrophizing [48 hours]
Aðgerðir vegna aukaatriða
1. Pain Intensity Measure VAS [48 hours]
2. Algometry [48 hours]